IMNM Competitors & Alternatives
Compare Immunome Inc with similar stocks in the same industry
Biotechnology
IMNM
Main Stock$19.48
Tradestie Score
61
Market Cap
$987.09M
Revenue Growth
-1.0%
Analyst Upside
+83.6%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IRON
Disc Medicine, Inc. Common Stock
|
$70.81
|
$2.33B | - | 59 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$36.40
|
$2.33B | - | 52 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.24
|
$2.23B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$18.57
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.85
|
$2.21B | - | 64 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.42
|
$2.18B | - | 61 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.74
|
$2.08B | - | 60 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.29
|
$2.02B | 49.7 | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$15.90
|
$2.01B | - | 56 | Compare |
More IMNM Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry